Fitbit unveils new wearables dedicated to wellness, stress-relief
The coronavirus pandemic took center stage at Fitbit’s swish virtual launch event for its new wearable fitness tech.
The Google-owned company was keen to point out that not only had it created emergency ventilators amidst COVID-19, but has added all sorts of measures to protect against the virus into its new products – including tracing apps, heart health features and more.
All in all, Fitbit pulled the wraps off three products: the Fitbit Sense, Versa 3 and Inspire 2.
Here’s what you need to know:
The Fitbit Sense might finally compete with the Apple Watch
The Sense is Fitbit’s best-attempt at a smartwatch yet. It adds stress-tracking via a new electro dermal activity sensor, along with a skin temperature sensor and the ability to take electrocardiograms (once it’s approved by your local health authority).
The Sense also packs built-in GPS, NFC Payments and an always-on display. Oh, and it also comes with six months of Fitbit’s Premium subscription service for free.
Versa 3 will go the distance
This is a solid upgrade to last year’s Versa 2. You get built-in GPS and a much better display. It’s slated to have a battery life of six days (although, we’d like to try that before we take their word on it) and it uses Fitbit’s Pure Pulse 2.0 tech (as does the Sense) to monitor your heart health.
As far as smartwatches go it is a bit on the bland side. But that said, it does do away with the buttons entirely.
The Inspire 2 is a tiny, budget-friendly tracker
Fitbit has not forgotten those who want a budget fitness tracker that doesn’t need to take center stage on your wrist. The Inspire 2 gives you the basics with step, calorie tracking and sleep monitoring.
The most exciting thing about the Inspire 2 is the slated battery life – ten whole days.
Apart from physical products, Fitbit said it had been participating in various studies that track symptoms of various diseases, including COVID-19. It said that soon it hopes to be able to use various sensors to perhaps make a diagnosis before you are even symptomatic.
They used one example in a study group that confirmed it could detect nearly 50% of COVID-19 cases a day before symptoms began. Fitbit has since submitted the study for peer review.
Esquire now has a newsletter – sign up to get it sent straight to your inbox.